Free Trial

Running Oak Capital LLC Acquires 7,183 Shares of STERIS plc (NYSE:STE)

STERIS logo with Medical background

Running Oak Capital LLC grew its stake in STERIS plc (NYSE:STE - Free Report) by 12.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,459 shares of the medical equipment provider's stock after purchasing an additional 7,183 shares during the period. Running Oak Capital LLC owned about 0.07% of STERIS worth $15,063,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Avalon Trust Co bought a new position in STERIS in the 4th quarter valued at approximately $30,000. Grove Bank & Trust grew its stake in shares of STERIS by 4,733.3% during the first quarter. Grove Bank & Trust now owns 145 shares of the medical equipment provider's stock worth $33,000 after buying an additional 142 shares during the last quarter. Anfield Capital Management LLC increased its holdings in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares in the last quarter. ORG Wealth Partners LLC bought a new position in shares of STERIS in the 1st quarter valued at $43,000. Finally, Brown Brothers Harriman & Co. lifted its stake in shares of STERIS by 66.7% in the 4th quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 88 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

Insider Buying and Selling at STERIS

In related news, SVP Cary L. Majors sold 12,828 shares of STERIS stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $250.08, for a total value of $3,208,026.24. Following the sale, the senior vice president now owns 11,372 shares of the company's stock, valued at approximately $2,843,909.76. The trade was a 53.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Daniel A. Carestio sold 17,626 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $242.56, for a total value of $4,275,362.56. Following the completion of the transaction, the chief executive officer now owns 51,385 shares in the company, valued at approximately $12,463,945.60. The trade was a 25.54% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.07% of the company's stock.

STERIS Stock Up 0.4%

NYSE STE traded up $0.87 during trading hours on Wednesday, hitting $240.46. The company's stock had a trading volume of 534,990 shares, compared to its average volume of 547,357. The company has a market capitalization of $23.65 billion, a PE ratio of 38.78 and a beta of 0.94. The company has a current ratio of 1.96, a quick ratio of 1.39 and a debt-to-equity ratio of 0.29. STERIS plc has a 52 week low of $200.98 and a 52 week high of $252.79. The company's 50-day simple moving average is $235.67 and its two-hundred day simple moving average is $223.81.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 EPS for the quarter, beating the consensus estimate of $2.59 by $0.15. STERIS had a net margin of 11.26% and a return on equity of 14.21%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the prior year, the company posted $2.58 earnings per share. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. Research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 0.95%. The ex-dividend date is Tuesday, June 10th. STERIS's dividend payout ratio is 36.77%.

Analyst Upgrades and Downgrades

STE has been the topic of a number of research reports. JMP Securities boosted their price objective on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a research report on Friday, May 16th. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Morgan Stanley upped their price objective on STERIS from $240.00 to $260.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Citigroup reiterated an "outperform" rating on shares of STERIS in a report on Friday, May 16th. Finally, Wall Street Zen raised shares of STERIS from a "buy" rating to a "strong-buy" rating in a report on Saturday, June 14th. Three analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, STERIS presently has an average rating of "Moderate Buy" and a consensus price target of $263.83.

Check Out Our Latest Analysis on STERIS

STERIS Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Should You Invest $1,000 in STERIS Right Now?

Before you consider STERIS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.

While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines